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Abstract
Background
Yin Yang 2 (YY2) is a zinc finger protein closely related to the well-characterized Yin Yang 1
(YY1). YY1 is a DNA-binding transcription factor, with defined functions in multiple develop-
mental processes, such as implantation, cell differentiation, X inactivation, imprinting and
organogenesis. Yy2 has been treated as a largely immaterial duplication of Yy1, as they
share high homology in the Zinc Finger-region and similar if not identical in vitro binding
sites. In contrast to these similarities, gene expression alterations in HeLa cells with attenu-
ated levels of either Yy1 or Yy2 were to some extent gene-specific. Moreover, the chromatin
binding sites for YY2, except for its association with transposable retroviral elements (RE)
and Endogenous Retroviral Elements (ERVs), remain to be identified. As a first step
towards defining potential Yy2 functions matching or complementary to Yy1, we considered
in vivo DNA binding sites of YY2 in trophoblast stem (TS) cells.
Results
We report the presence of YY2 protein in mouse-derived embryonic stem (ES) and TS cell
lines. Following up on our previous report on ERV binding by YY2 in TS cells, we investi-
gated the tissue-specificity of REX1 and YY2 binding and confirm binding to RE/ERV tar-
gets in both ES cells and TS cells. Because of the higher levels of expression, we chose TS
cells to understand the role of Yy2 in gene and chromatin regulation. We used in vivo YY2
association as a measure to identify potential target genes. Sequencing of chromatin
obtained in chromatin-immunoprecipitation (ChIP) assays carried out with αYY2 serum
allowed us to identify a limited number of chromatin targets for YY2. Some putative binding
sites were validated in regular ChIP assays and gene expression of genes nearby was
altered in the absence of Yy2.
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Conclusions
YY2 binding to ERVs is not confined to TS cells. In vivo binding sites share the presence of
a consensus binding motif. Selected sites were uniquely bound by YY2 as opposed to YY1,
suggesting that YY2 exerts unique contributions to gene regulation. YY2 binding was not
generally associated with gene promoters. However, several YY2 binding sites are linked to
long noncoding RNA (lncRNA) genes and we show that the expression levels of a few of
those are Yy2-dependent.
Introduction
The Yin Yang 2 (Yy2) gene is a retrotransposon-derived paralog of the Yy1 (Yin Yang 1) gene,
and is both conserved and active in all placental mammals [1]. In the mouse, the Yy2 gene is
localized on the X chromosome, where it is embedded in a complex locus shared with another
gene, namelyMbtps2 [2]. The Yy2 gene encodes a 378 AA protein, which shares 56.2% identity
overall with YY1. While the N-terminal region of YY2 is very different at the amino-acid level
from the N-terminal region of YY1, the C-terminal region encoding four Gli-Kruppel type zinc
finger domains is very well conserved (86.4% identity between YY1 and YY2). Consistent with
the high level of sequence conservation, both YY1 and YY2 bind a consensus YY1 binding
motif [3]. Similarly, largely identical motifs are bound by YY1 and YY2 when high affinity
binding sites are selected for in vitro [1]. Moreover, competition between YY1 and YY2 for
binding to virus-responsive binding sites has been proposed to underlie activation of the IFNβ
gene [4]. Interestingly, in vitro binding assays also unveiled that YY1 and YY2 interact with
RYBP and selected Polycomb group proteins [5].
YY1 is a transcription factor with sequence context-dependent activation or repression
activity, which controls the transcription of a large number of viral and cellular genes [6]. Loss-
of-function models have implicated YY1 in gene regulation underlying fundamental biological
processes such as proliferation, cell cycle regulation and cytokinesis [7]. Considering all simi-
larities between YY1 and YY2, functional redundancy has been implied. Nevertheless, the bio-
logical functions of YY2 have not been well characterized and loss-of-function models in the
mouse are not available. Moreover, partial deficiency in HeLa cells revealed distinct Yy1 or
Yy2-dependent alterations in gene expression [8].
In vivo, YY1 and YY2 share DNA binding to transposable retroviral elements (RE) [9], par-
ticularly to selected members of the family of Endogenous retroviral elements (ERVs) [10].
ERV represent a category of repeat sequences that result from retroviral insertions in the germ-
line. ERVs occupy 8–10% of mammalian genomes, and can be grouped into families based on
sequence homology. Within each family, a multitude of very similar but distinct elements can
be distinguished that are scattered across the genome. Most copies have accumulated muta-
tions rendering them incompetent for infection and/or mobilization. Independent of their
mobilization activities, ERVs impact the transcriptional activities of neighboring genes through
promoter and long-range effects. ERV are active especially in germ cells, placenta and preim-
plantation embryos (reviewed in [11, 12]). Subtle differences in binding preference were obvi-
ous when comparing in vivo binding of YY1 family members to ERV elements [10].
During preimplantation development the first differentiation steps take place in the embryo,
separating the inner cell mass (ICM) from the trophectoderm (TE), which give rise to the
embryo proper and extra-embryonic tissues, respectively. Gene expression underlying these
steps is governed in part by mechanisms unique to these particular stages and cell types
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[13, 14]. These include the maintenance of allele-specific expression of particular genes based
on parental-origin specific methylation patterns (imprinting), and consecutive re-activation
and inactivation of one of the X chromosomes in females (XCI). Both REX1 and YY1 are
expressed during late preimplantation mouse development [15, 16]. YY1 is essential in this
period, since Yy1-loss-of-function does not allow embryonic development beyond implanta-
tion [15]. YY1 also binds imprinted genes in a methylation-dependent way [17, 18] and both
YY1 and REX1 contribute to XCI [18–20]. Although both YY1 and REX1 contribute to mam-
malian-specific processes such as embryo implantation, imprinting and XCI, such functions
have not yet been described for Yy2. We considered the presence of YY2 in embryonic stem
(ES) and trophoblast stem (TS) cells, as models for ICM and trophoblast precursors, respec-
tively. We detected increased levels of Yy2 in TS cells and decided to assess a regulatory role of
YY2 in TS cells. In line with the apparent abundant presence of YY2 in TS cells, we initiated a
search for genomic targets in addition to previously identified transposons. Binding sites iden-
tified were validated in ChIP assays and shown to uniquely bind YY2 as opposed to YY1.
Moreover, several long noncoding RNAs (lncRNAs) linked to YY2 binding sites are moder-
ately affected by Yy2-deficiency, suggesting YY2-dependent regulation.
Materials and Methods
Immunological reagents andWestern blot
The αYY2 and the αREX1 sera raised in rabbit have been described previously [10]. The ami-
noterminal region of YY2 (aminoacids 1–173) used for immunization does not show much
homology to the corresponding region in YY1 [1], and does not cross-react with YY1 (S2 and
S3 Figs). The rabbit αYY2 serum was further affinity-purified over YY2α-GST protein (Immu-
noStep SA, Salamanca, Spain). Monoclonal αHA (clone HA-7) was obtained as an unpurified
ascites fraction (Sigma H9658).
For Western blot analysis, cells were washed twice with ice-cold PBS on the plate, scraped,
resuspended in lysis buffer (0.25 M Tris–HCl (pH 7.8), 0.1% NP-40) containing protease inhib-
itors (PMSF, Sodium Ortovanadate and Complete; ROCHE) and protein stabilizers (DTT) as
described [21]. Samples with added Laemmli sample buffer were subjected to SDS–polyacryl-
amide gel electrophoresis, transferred to nitrocellulose membranes (Hybond-P, Amersham).
Standard Western blot was performed using αYY2, αREX1, αYY1 or αTUBULIN antibodies.
Horseradish peroxidase-coupled αIgG secondary antibodies (Dako, α-mouse (1:2500), α-rab-
bit (1:10000)) were detected using chemiluminescence (ECLWestern Blotting Detection,
Amersham Biosciences). Before blocking and reprobing with a different primary antibody,
membranes were stripped by incubation in 1 M glycine (pH 2.5) for 20 min at RT, followed by
incubation in Tris-HCl pH 7.4 and TBS (50 mM Tris-Cl, pH 7.5; 150 mMNaCl) for 1 minute
each.
Indirect immunofluorescence and confocal microscopy
Cells were cultured on gelatin-coated coverslips for at least 4 h to attach. Cells were fixed with
4% paraformaldehyde in PBS (pH 7.4), permeabilized in 0.5% Triton-X100 for 10 min and
incubated overnight at 4°C with a rabbit αYY2 antibody (1:4800) in PGBA (0.1% gelatin, 1%
BSA, 0.05% NaAzide in PBS, pH 7.4)/10% FBS. All further steps were performed at RT. Cells
were washed three times and incubated with an α-rabbit biotin antibody (1:500) for 30 min
and with streptavidin-Alexa 488 (1:200) for 45 min both in PGBA. Nuclei were counterstained
with DAPI (10 μg/ml) in PBS for 10 min. Coverslides were mounted in glycerol/DABCO 2.5%/
50 mM Tris pH 8.6 (DTG). Negative controls were performed using the same procedure with-
out the addition of primary antibody. Widefield microscopy images were obtained in an
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Olympus upright fluorescence microscope (BX60) with 40X objective. Confocal sections were
obtained in an Olympus confocal microscope Fluoview FV1000 with a 60X objective. Images
were pseudocolored in green for YY2 and DAPI in blue (cell nuclei).
Cell culture, differentiation, transfection and separation
The mouse TS cell line B7 [22] was maintained as described [23] on 1% gelatin-coated tissue
culture dishes and the presence of 70TS-CM supplemented with FGF4 (25 ng/ml) (Peprotech)
and heparin (1 mg/ml) (Sigma) [5]. ES cell line E14T [24] was maintained on gelatin-coated
tissue culture dishes in medium supplemented with 10% fetal calf serum, leukemia inhibitory
factor (LIF) as described [25]. E14T ES cells were transfected with plasmids expressing
shRNAs, selected with Hygromycin for 7 days as described before [5], and processed for West-
ern blot. Attenuation of Yy2 levels in TSB7 cells was achieved by introduction of vectors that
express short hairpin RNA (shRNA) and GFP [10]. shRNA sequences introduced in different
vectors are as follows: shYy2: 5´ CAATACCACTCTCCTGTTATT; shControl: 5´ AAGCGC
GATCACATGGTCCTG. A detailed description of shYy2 sequences used for knockdown is avail-
able in a manuscript in preparation [26]. Cells seeded the day before transfection (0.8 ×106
cells per 30 mm dish) were transfected with Lipofectamine 2000 according to manufacturer's
instructions (Invitrogen), using 4 μg of the plasmid of interest as described previously [5]. Cells
were dissociated 16–24 h after transfection, suspended in TS medium supplemented with 1%
FBS and 10 mMHEPES (Sigma) (2 × 106 cells/ml). Cell sorting was performed on a FACSAria
(BD BioSciences) equipped with a 488 nm laser and operated by the Flow Cytometry and Cell
Separation Unit at CIBA, IACS, Zaragoza. GFP+ and GPF- sorted cells were collected in PBS/
10% FBS. Cells were spun down, lysed in TRIzol1 reagent (Invitrogen) and processed for
qPCR analysis as described below.
Gene expression analysis: RT-qPCR
Cells were washed with PBS, scraped and total RNA was extracted using TRIzol1 reagent
(Invitrogen). After digestion of genomic DNA (RQ1 RNAse-Free DNase, Promega), RNA was
extracted with phenol/chloroform, precipitated with ethanol, re-suspended in water and quan-
tified using Nanodrop (Thermo Scientific). cDNA was synthesized from 2 μg of RNA with ran-
dom hexamer primers (ThermoScript1 RT-PCR System, Invitrogen) and stored at -20°C until
used. cDNA was analyzed by quantitative PCR (Platinum1 SYBR1 Green qPCR SuperMix-
UDG, Invitrogen) on an ABI Prism 7000 Real-Time PCR system, reactions were performed in
triplicate. To compare expression levels between cell types, data obtained in at least two (and in
most cases three) independent samples were processed using the ΔΔCt method [27], using
Gapdh as a reference gene. To compare the capacity of different primer pairs to amplify anno-
tated transcripts in theMbtps2/Yy2 locus, ΔCt values using Gapdh as a reference gene were cal-
culated. Sequences of all primers used are included in S1 Table. Standard curves of all primers
(used at 200 nM) were performed to assure efficient amplification (between 90% and 110%).
Melting curves were also performed to verify production of single DNA species with each
primer pair, except for ERV sequences.
Chromatin Immunoprecipitation (ChIP) and locus-specific PCR
ChIP assays were performed as described [5, 10] with the following minor modifications. 5 x
106 cells for each experimental condition were chemically crosslinked for 15 min at room tem-
perature by the addition of fresh 37% formaldehyde solution to a final concentration of 1%
(v/v). After the addition of glycine to a final concentration of 125 mM to stop the crosslink,
cells were rinsed twice with PBS and harvested by scraping. Cells were resuspended in lysis
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buffer (50mM Tris-HCl (pH 8.1), 10mM EDTA, 1% (w/v) SDS) and protease inhibitors (Com-
plete™, Roche) and sonicated in a Diagenode sonicator (30 second pulses, 30 second pause
between pulses). Per 5 × 106 cells the following sera were used for immunoprecipitation (IP):
preimmune serum (PreI) (75 μg), rabbit anti-REX1 IgG (75 μg), mouse monoclonal H-10 anti-
YY1 (Santa Cruz, 2.5 μg), rabbit anti-YY2 (25 μg). We compared semi-quantitative PCR ampli-
fication on amounts of chromatin obtained from the same number of cells after immunopre-
cipitation using either PreI, αYY2 or αREX1 serum. PCR products were visualized using
ethidium bromide and photographed. Primers used are listed in S1 Table.
Quantitative real-time PCR on ChIPs was performed in triplicate reactions as described
above and processed using the ΔCt method. Amplification was performed in 15 μl reactions
using the following parameters: 50°C for 2 min, 95°C for 10 min followed by 40 cycles of (95°C
15 s, 60°C 60 s). Data presented show the aggregate of a minimum of two (and often three) sep-
arate ChIPs performed on different days, unless indicated otherwise. Enrichment levels were
calculated as a percentage of immunoprecipitation relative to the input as described (www.
SABiosciences.com). Data are shown as fold enrichment of a particular locus compared to con-
trol loci.
High-throughput sequencing
ChIPped DNA for high-throughput sequencing was obtained by standard ChIP experiments
using αYY2 or PreI serum as described above. High-throughput sequencing was performed by
Fasteris SA (CH-1228 Plan-les-Ouates, Switzerland) on an Illumina Hi-Seq 2000 instrument
according to manufacturer provided protocols with minor modifications. The Burrows-
Wheeler Alignment Tool (0.5.9) was used to map the reads (50 nt) against the mouse genome
(Mus Musculus—Version mm9, NCBI assembly M37), only quality-filtered reads were
retained for downstream analyses. Mapping was carried out allowing a maximum of 1 mis-
match per read. Reads mapping to several positions on the reference genome with the same
mapping quality were considered repeated (R), and assigned a location by randomization.
Additional data related to each of the resulting datasets is shown in Table 1, specific ChIP
using αYY2 was compared to ChIP using PreI serum.
Mapping results were loaded into the software SeqMonk (Version V0.16.0, License GPLv3)
to identify peaks. SeqMonk counts reads in fixed size windows of 100 bp (step size = 50 bp).
Counts in the YY2 dataset were multiplied by 1.62 to normalize for the number of mm9-
mapped reads in each dataset, and counts of 0 were substituted for 1 to allow the calculation
of ratios. We assigned an arbitrary score to each peak identified, which was calculated as the
Table 1. Sequencing data.
αYY2 PreI
initial number of quality-filtered reads 14746400 23649193
number of mm9 mapped reads 13369042 21612138
% of mapped reads respect to the initial number 90.66% 91.39%
number of reads mapped at unique positions 11056749 18052709
% number of reads mapping at unique positions ** 74.98% 76.34%
number of reads mapping at multiple positions 2312293 3559429
% of reads mapping at multiple positions 15.68% 15.05%
Sequencing results. High-throughput sequencing was carried out on DNA obtained from chromatin
immunoprecipitations (ChIPs) carried out using either αYY2 or PreI serum. The table shows sequencing
and mapping data (**, % relative to the number of mm9 mapped reads).
doi:10.1371/journal.pone.0154268.t001
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number of reads in αYY2 IP divided by the number of reads in the PreI sample in the same
area (unique and repeated reads combined). The peaks were then ranked from high to low
numbers, and annotated with the closest gene or database feature (within a range of 100 kb).
ChIPseq data are freely available at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE80824. To find overrepresented sequence motifs, search programs [28] were accessed
through http://rsat.ulb.ac.be/rsat. The sequences of the top 20 peaks were used as input for
CONSENSUS [29]. The best obtained position weight matrix was found to be comparable to
motifs produced by alternative software such as MEME [30].
Results
Expression of YY2 in blastocyst-derived stem cells
We obtained a rabbit αYY2 serum after immunization with an YY2-GST fusion protein (see
M&M), which easily detects the fusion protein in Western blot (S1A Fig). Furthermore, the
serum detects HA-YY2 in the nucleus of transfected 293T cells using immunofluorescence
(S1B Fig). The serum allowed the detection of endogenous YY2 protein in extracts from mouse
ES cells by Western blot (S1C Fig). The presence of the approximately 60 kD band correspond-
ing to YY2 was substantially reduced in extracts from cells transfected with shRNAs directed
against Yy2 (S1C Fig). Epitope detection by the serum in Western blot was abolished after
saturation with excess binding protein (S1A Fig), confirming the specificity of detection. We
expected the serum to be specific for YY2 as the YY2 portion used for immunization shares lit-
tle homology with YY1 (S2 Fig). This was confirmed by Western blot, as the YY2 serum used
does not immunoprecipitate or detect HA-tagged YY1 in Western blot as opposed to HA-
tagged YY2 (S3A and S3B Fig).
Although Yy2 expression has been described as rather ubiquitous (although divergent levels
have been reported [31]), its presence in preimplantation embryos or stem cells derived thereof
has not been described so far. As in vitromodels of either the ICM or the trophectoderm, we
analyzed the presence of immuno-reactivity against the αYY2 serum in ES cells (line E14T)
and TS cells (line B7) by indirect immunofluorescence. Staining patterns were analyzed by con-
focal microscopy and representative images are depicted in Fig 1A and S4 Fig. No staining was
observed in either cell type when PreI serum or no primary antibody was used (data not
shown). In ES cells, YY2 staining was apparent (panels YY2), mostly confined to the nucleus as
revealed by nuclear counterstaining (panel DAPI). This pattern was confirmed by staining of
HA-YY2 in the nucleus of transfected 293T cells (S1B Fig). Most if not all TS cells also showed
detectable reactivity with the anti-YY2 serum (Fig 1A, panel TS). Similar to ES cells, staining
was most intense in the nucleus. YY2 (green) displays a predominantly nuclear localization in
ES and TS cells, although some weak staining was observed in the cytoplasm of TS cells.
To further confirm the presence of YY2 in ES and TS cells we also tested Yy2mRNA levels
in blastocyst-derived stem cell lines in tissue culture by PCR. Expression of H2Afz was used as
a control for the quality of the RNA and cDNA used. BothH2afz and Yy2mRNA were easily
detected in both cell types (Fig 1B). Yy2 transcript levels were analyzed by quantitative PCR
and compared to the levels of several lineage-specific transcription factors. Expression of Oct4,
Sox2 and Nanog was confined to ES cells as expected (Fig 1C), and the converse was true for
Cdx2 and Eomes. Yy2 was detected in ES cells at levels similar to Nanog. Relative to expression
levels in ES cells (assigned arbitrarily a 100% level), we detected levels in TS cells at about 400%
(Fig 1D).
Transcripts encoding YY2 are generated from a complex locus that also produces a variety
of transcripts calledMbtps2 [2]. The major transcriptMbtps2-001 is expressed at comparable
levels in both TS and ES cells (Fig 1D). TheMbtps2 locus produces various transcripts
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Fig 1. Yy2 andMbtps2 expression in ES and TS cells. (A) Expression of YY2 was detected by indirect immunofluorescence in ES cells and TS
cells. YY2 was visualized using αRabbitBiotin followed by StrepAlexa488, nuclei were stained with DAPI (blue). (B) An EtBr stained gel shows PCR
products generated with either Yy2 or H2afz-specific primers (as indicated), after amplification of cDNA obtained from ES and TS cells. (C) Expression
of Yy2 and cell type-specific markers (or lineage markers) of ES cells (Oct4, Sox2, Nanog) or TS cells (Cdx2, Eomes) was measured by RT-qPCR.
Gene expression was normalized toGapdh and data is represented as the mean ± SEM. (D) Expression of Yy2 andMbtps2-001 was detected by
quantitative RT-PCR in (E14T) ES cells or (TSB7) TS cells (error bars represent SEM). Transcript levels were normalized to H2afz and to the
expression in ES cells (100%).
doi:10.1371/journal.pone.0154268.g001
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(S5A Fig), including several that overlap directly with Yy2. To discriminate properly between
transcripts transcribed from this locus that encode either MBTPS2 or YY2, we extended our
analysis to include the mRNA levels of several annotatedMbtps2 variant transcripts using
qPCR. Results (S5 Fig) demonstrate the presence in TS cells of both the canonicalMbtps2-001
transcript and of aMbtps2-003 transcript. Although this transcript is namedMbtps2-003, it is
identical to the Yy2-201 transcript and the putative protein encoded in the 5´end is not repre-
sented in the protein database (Swiss Prot). In accordance with the hypothesis that theMbtps2-
003 transcript is identical to the Yy2-201 transcript, amplification efficiencies (Cts, S5B Fig)
obtained usingMbtps2-003–specific primers (primer set D) are almost identical to those
obtained using primers in the Yy2 coding region (primer sets A, B; S5 Fig). Assays aimed at the
detection of different exons of theMbtps2-002 transcripts that might overlap with the Yy2
locus (S5A Fig) yielded Ct values in a high range compatible with lack of expression (S5B Fig).
Altogether, we conclude that the Yy2 transcript levels measured (Fig 1D) can be attributed to
YY2-encoding transcripts, without interference from transcription that covers theMbtps2
gene.
REX1 and YY2 binding to ERVs of different families in different stem
cells
Previously, we reported the association of REX1 (in ES cells) and YY2 (in TS cells) to several
transposable retroviral elements [10], albeit with differing specificity of either protein for
muERV-L and IAP elements, respectively. However, REX1 binding in ChIP assays may be tis-
sue-specific [5]. To assure that the differences observed reflect binding specificities as opposed
to cell type differences, we re-assessed binding of both factors to a subset of genomic repeats
derived from LTR retrotransposons in ES and TS cells. As before, we carried out ChIP assays to
demonstrate in vivo association of either REX1 or YY2 to a subset of ERV. After subtraction of
background values and normalization against a control promoter, hardly any enrichment was
observed for several control markers, i.e. different nonspecific genomic regions (CGR-A,
CGR-B), or multi-copy sequences (MLV36, y-satellites) in both cases (Fig 2A and 2B).
We now assayed for REX1 binding in undifferentiated TS cells. In chromatin immunopre-
cipitated from TS cells using αREX1 (Fig 2A), we demonstrate a several-fold enrichment of
both IAP and muERVL elements, and a weaker enrichment of musD elements. REX1 associa-
tion to the same ERV was lower in TS cells (Fig 2) as opposed to ES cells [10, 32], in line with
reduced expression of Rex1 in TS cells [5]. In contrast to ES cells, enrichment for IAP elements
was as high as for muERV-L (Fig 2A). Although the ratio of binding in TS cells relative to ES
cells was slightly different for individual elements, REX1 associated to the same elements in
both cell types.
YY2 associated with specific ERV elements in TS cells [10]. As YY2 was also detectable in
ES cells (Fig 1), we re-assessed chromatin binding in these cells to assay for potential tissue-spe-
cific binding. Enrichment of a subset of ERVs in ChIP assays was also detected in ES cells. We
observed a reproducible 3-fold enrichment of the IAP locus in chromatin immunoprecipitated
using αYY2 in ES cells (Fig 2B). To a lesser extent, reproducible enrichment was also detected
for musD and muERVL elements (Fig 2B). The association of YY2 to IAP was slightly stronger
as compared to muERVL in both TS cells [10] and ES cells (Fig 2), indicating that the binding
specificities of YY2 did not show cell type specificity. We also calculated a weak but reproduc-
ible 2-fold enrichment of the MalR and Orr1 loci in chromatin immunoprecipitated using
αYY2 in ES cells (Fig 2C). By contrast, no reproducible enrichment was detected for Tsix and
Spata24, loci efficiently bound by REX1 in ES cells [33]. In conclusion, YY2 associates with a
subset of genomic repeats derived from LTR retrotransposons, displaying the highest affinity
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Fig 2. REX1 and YY2 bind RE/ERV elements in both ES and TS cells. (A) REX1 association to RE in TS cells. Binding was assessed in
chromatin immunoprecipitation assays using αREX1 serum followed by quantification of precipitated DNA using real-time qPCR amplification.
The figure shows analysis of non-binding reference sites as controls (CGR-A, CGR-B), andGapdh, several sequences present in the genome as
multiple copies (MLV36, γ-satellite) and the ERV elements indicated. Association is represented as percentage bound (relative to purified
chromatin extract from the same lysate). Enrichment was calculated as percentage association relative to control chromatin, and is represented
as fold binding or enrichment relative to a non-binding reference geneGapdh. Error bars indicate SEM. (B) As A except for YY2 binding in ES
cells. Data on CGR-A, CGR-B andmusD are from a single experiment. (C) YY2 binding to Class III elements. Binding of YY2 in ES cells to class
III ERV sequences present in the genome as multiple copies (Orr1 andMalR) was assessed by qPCR analysis as described inA. The figure
shows fold enrichment relative to a non-binding reference geneGapdh. Data on CGR-C,musD, Tsix and Spata are from a single experiment.
doi:10.1371/journal.pone.0154268.g002
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for IAP elements in both TS and ES cells. This result confirms our previous observation [10]
that the in vivo association of YY2 to LTR retrotransposons is similar to but not identical to
REX1.
Identification of in vivo YY2 chromatin binding sites in TS cells
Taking into account that YY2 was easily detected in TS cells (Fig 1) and associated with specific
ERV elements in these cells (Fig 2; [10]), we continued our functional analysis of Yy2 in these
cells. To identify YY2 binding sites in TS cell chromatin, ChIP experiments were carried out as
before, and chromatin fractions obtained were sequenced (ChIPseq experiment, see M&M).
YY2 binding sites were identified as regions with higher numbers of reads (peaks). A score
based on the number of reads (see M&M) was assigned to each peak, and peaks were subse-
quently ranked from high to low numbers (Table 2). The total number of peaks identified with
an enrichment score higher than 2 was 483 (data not shown), while 58 peaks scored above 4
(maximum 15). As these scores were relatively low, genome-wide coverage was probably not
attained. Nevertheless, this procedure yielded a list of potential in vivo YY2 binding targets. In
the absence of a biological replicate dataset, we validated YY2 binding to several of the putative
binding sites.
As binding loci did not correspond to genes in a straightforward pattern, we assigned codes
to binding sites (Table 2) without references to adjacent genes. When association was assayed
using semi-quantitative PCR (Fig 3A), efficient amplification was observed using control tem-
plates for each of the loci analyzed (lanes NoIP), and hardly any amplification was observed for
the majority of markers with PreI serum (lanes PreI). By contrast, we observed reproducible
association of YY2 to the T13T1 and T18T1 loci, as opposed to an intergenic fragment in chro-
mosome 6 (data not shown) and the Gapdh promoter (Fig 3A), which were not amplified
above background. Enrichment of binding sites in ChIP assays was also measured by qPCR.
We calculated a reproducible 2 fold enrichment of the T18T1 locus in chromatin immunopre-
cipitated using αYY2 in TS cells (Fig 3B). Weak but reproducible enrichment was also detected
for T11T1 and T13T1 sites (Fig 3B). This enrichment was observed irrespective of its represen-
tation as fold enrichment (Fig 3B) or as percentage of input chromatin (Fig 3C). These results
validate the peaks identified as putative YY2 binding sites in TS cells (Table 2).
Absence of YY1 association to in vivo YY2 binding sites
All validated YY2 binding sites (Fig 3B) were taken from the top 20 binding sites according to
enrichment score (Table 2). We searched the combined sequences in this list of 20 for a poten-
tial YY2 binding motif. Analysis revealed the presence of a consensus binding site ANA-
GAAGTGG (N indicating any residue), shown as a sequence logo in Fig 4A. This motif is
present in all 20 sequences analyzed with a P-value 7.38e-04, (data not shown). Furthermore,
this motif shares similarity with an AANATGG motif identified previously in vitro [1]. This
data suggests that the sequences identified are bound directly by YY2 protein at a defined
motif.
As YY2 shares high homology in the DNA binding zinc fingers with YY1 [1], we tested
their mutual binding to several of the putative binding sites for YY2 identified in TS cells (Fig 4
and Table 2). In addition, a binding site S5T1 with a rather low enrichment score (position
455) was also included as it obtained the maximum score when only reads mapping to multiple
locations in the genome were taken into account. We carried out ChIP assays in combination
with locus-specific qPCR as before, using either αYY2 or αYY1. Enrichment of particular loci
was normalized against the Gapdh promoter (Fig 4B). As a control, we used a YY1 binding site
identified in genome-wide location analysis of YY1 in ES cells [34]. Using αYY2 to corroborate
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YY2 binding, we calculated reproducible enrichment of several YY2 binding sites, including
T5T1, S5T1 and T18T1. In ES cell-derived chromatin immunoprecipitated using αYY1 (Fig
4B), we obtained a 7–8 fold enrichment of the YY1T1 control locus, as opposed to the negligible
enrichment of YY2 target sites. These results demonstrate mutually exclusive binding of YY1
and YY2, and suggest that in vivo binding sites for YY1 and YY2 differ, in line with subtle dif-
ferences encountered in the consensus binding site in vitro [1, 3].
Expression of putative YY2 targets as a function of Yy2 levels
While YY2 selectively binds to IAP and MERVL retroviral elements in TS cells ([10]; Fig 2B),
potential changes in the expression levels of these retrotransposons as a function of Yy2 levels
have not been addressed so far. We compared the expression levels of these elements between
control TS cells and TS cells that carry shRNA-expressing vectors to attenuate Yy2 expression
levels. While Yy2 levels were severely reduced under these conditions and represented only
20% of the levels detected in control cells (Fig 5A), we detected only minor differences between
the expression levels of either IAP orMERVL in Yy2-depleted TS cells (Fig 5B).
Among the genes associated with YY2 peaks (Table 2) are the cell-cycle regulators Cdkl2 (peak
4) and Apc (peak 19), with binding sites at 2.6 kb and 54.5 kb upstream of the Transcription Start
Table 2. Putative in vivo YY2 binding sites.
Peak N° Code Chr Location Features Description
1 17 4626100 4626650 U6.463 U6 spliceosomal RNA
2 4 146794200 146794350 Gm16889 predicted gene, 16889 Gene
3 4 145702600 145702850 Gm13247 predicted gene 13247 Gene
4 T5T1 5 92432350 92432500 Cdkl2 cyclin-dependent kinase-like 2 (CDC2-related kinase) Gene
5 3 66084950 66085100 Veph1 ventricular zone expressed PH domain homolog 1 (zebrafish) Gene
6 18 3009150 3009250 null
7 6 144393150 144393300 Sox5 SRY-box containing gene 5 Gene
8 8 19932850 19933000 Gm10348 predicted gene 10348 Gene
9 7 101995950 101996050 null
10 4 146017850 146017950 Gm13051 predicted gene 13051 Gene
11 13 65753950 65754100 AC116589.1 No description
12 5 96865250 96865400 Fras1 Fraser syndrome 1 homolog (human) Gene
13 7 97373550 97373700 Ccdc83 coiled-coil domain containing 83 Gene
14 8 9597100 9597250 Fam155a family with sequence similarity 155, member A Gene
15 T11T1 11 19506300 19506400 Gm12027 predicted gene 12027 Gene
16 12 92957600 92957700 Ston2 stonin 2 Gene
17 T13T1 13 41048000 41048100 Gcnt2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme Gene
18 15 63758200 63758300 Fam49b family with sequence similarity 49, member B Gene
19 T18T1 18 34326250 34326350 U7.84 U7 small nuclear RNA
20 14 20428900 20429000 Gm5458 predicted gene 5458 Gene
High-throughput sequencing was carried out on DNA obtained from chromatin immunoprecipitations (ChIPs) carried out with αYY2 serum. Reads were
mapped to the mouse genome (Version mm9, NCBI assembly M37). The table shows data related to the 20 most significant peaks based on enrichment
in the αYY2 dataset compared to the control dataset. The table lists the chromosomal localization of each peak, and the nearest annotated feature in the
database within a range of 100 kb. Codes used to identify loci in ChIP assays are indicated as well. Note that several features in the table have changed
names in the mm10 version of the mouse genome (NCBI GrCm38): Gm16889 has been renamed as C230088H06-Rik and Gm10348 has been replaced
by first Gm17279-201 and later Gm26804-201.
doi:10.1371/journal.pone.0154268.t002
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Site (TSS), respectively. To establish a direct functional link between YY2 protein binding and
gene regulation, we compared the mRNA expression levels of these genes in TS cells with attenu-
ated levels of Yy2. We detected only small differences in expression levels of either protein-coding
genes Cdkl2 and Apc upon Yy2 depletion (Fig 5C).
Fig 3. YY2 binding to genomic targets. (A) Semiquantitative PCR and (B) qPCR to validate YY2 association in TS cells to peaks identified by
sequencing (Table 2). (A) EtBr stained gel shows PCR products of the genomic regions immunoprecipitated by YY2 (αYY2). Preimmune serum
(PreI) was used as a control. Purified chromatin extract from the lysate was used to confirm amplicons. MQ, reactions without input DNA served as
a negative control.Gapdh promoter was used as a reference gene. (B) Association of YY2 in TS cells to potential genomic targets (Table 2) was
assessed by locus-specific qPCR analysis after chromatin immunoprecipitation using αYY2, or preimmune serum (PreI) as a control. TheGapdh
promoter is included as a negative control. The amount of immunoprecipitated DNA as a percentage of input DNA was recalculated as fold
association normalized to theGapdh promoter. Error bars represent SEM. (C) As B, data is represented directly as a percentage of input DNA.
Each panel represents an independent experiment.
doi:10.1371/journal.pone.0154268.g003
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In vivo YY2 binding sites linked to lncRNA genes
We surveyed the most significant YY2 binding sites (S2 Table and Fig 5E) for genes nearby.
To the 20 peaks identified by the highest combined number of unique and repeated reads
(Table 2) we added a site in the Speer7-ps1 locus (indicated as S5T1) that obtained the maxi-
mum score when only reads mapping to multiple locations in the genome were taken into
account. Surprisingly, these binding sites were not confined to or preferentially located in gene
promoters of protein-coding genes as might be expected [3, 7]. Only two of these 21 peaks
mapped within kilobases (kb) of the nearest TSS (S2 Table and Fig 5E). Among the most signif-
icant peaks surveyed (S2 Table), several (eight) are located overlapping transcribed sequences,
invariably far away from TSS (average distance around 70 kb). Other sites were located (far)
Fig 4. Association of YY1 and YY2 to chromatin. (A) A motif enriched in the genome wide YY2 ChIP-seq peaks is depicted as a sequence logo.
Data from the top 20 peaks were analyzed as described in M&M. (B) Association of YY1 (in ES cells) or YY2 (in TS cells) to genomic targets was
assessed as described in the legend to Fig 3B, using either αYY1 (left panel) or αYY2 serum (right panel). Codes for genomic targets analyzed refer to
a YY1 genomic target (YY1T1) and several YY2 target genes (T5T1, T18T1) from Table 2 (see text for S5T1). The data in the left panel represent the
average of three independent experiments ± SEM. The right panel shows the results of a typical experiment out of several performed, except for
T18T1, multiple replicates performed.
doi:10.1371/journal.pone.0154268.g004
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Fig 5. Expression analysis of genes associated with YY2 binding sites. (A-C) Gene expression levels in TS cells with
attenuated Yy2 levels. Cells were sorted by FACS after transfection with plasmids co-expressing shRNAs and GFP. Expression
of either Yy2 itself A, or of putative YY2 target genes B, C was compared between cells expressing a shYy2 sequence (GFP
+/ShYy2) and control cells (GFP-). All qPCR data were calculated usingGapdh as a reference gene and values are expressed
relative to GFP-negative ES cells from the same experiment (100%). Data shown represent the average of two or more
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downstream of transcribed genes (3/21), far upstream (6–60 kb, 6 sites) or more than 100 kb
away from annotated features (2/21) (Fig 5E). Interestingly, four out of 21 binding sites are
located either overlapping lncRNA genes or less than 5 kb away (S2 Table and Fig 5F). In addi-
tion, six more lncRNA genes are located within a 100 kb range of putative binding sites (Fig
5F). LncRNAs are a vast group of RNA molecules generally longer than 200 nucleotides that
do not encode proteins [35–37]. They are polyadenylated, and may undergo post-transcrip-
tional processing (5’ capping, splicing). While they are generally not highly expressed, they
contribute to tissue- and cell-type specific as well as imprinted gene expression [36, 38].
In view of the prominent association of YY2 binding sites with lncRNA genes, we decided
to include several of such genes in our analysis. Peak 2 (Table 2) overlaps three different
lncRNAs transcribed in different directions (Fig 5D); peak 8 overlaps the transcribed region of
a lncRNA named Gm26804-201 (referred to as Gm17279 in Table 2). We tested the expression
levels of all these genes in Yy2-depleted TS cells. While the levels of C230088H06-Rik-201 and
Gm26804-201 were independent of Yy2 levels, the expression levels of C230088H06-Rik-202
and Gm26624 were significantly induced in the absence of Yy2 (Fig 5G). These studies establish
a functional link between YY2 protein binding and regulation in cis of expression of selected
lncRNA genes.
Conclusions
1. YY2 is expressed at high levels in two cell types representative of blastocyst stage embryos
i.e. embryonic stem cells and in trophoblast stem cells.
2. YY2 binding to endogenous retroviral-like elements is not confined to TS cells and largely
independent of REX1.
3. We have mapped in vivo YY2 binding sites in mouse (trophoblast stem) TS cells.
4. YY2 binding sites identified share a consensus binding motif. This motif is related to but dif-
ferent from reported in vivo binding sites for YY1.
5. Based on the analysis of a limited number of binding sites, YY2 association in vivo is distinct
from YY1.
independent experiments ± SEM. No gene expression differences were observed between GFP positive and negative cells
transfected with a construct carrying a non-specific shControl sequence. (D) Representation of a lncRNA locus analyzed on
Chromosome 4 (GRCm38 Chr4:147018235–147491046). The primers utilized and the direction of transcription of the different
transcripts is indicated with arrows and horizontal arrowheads, respectively. The location of the relevant YY2 peak number 2
(Table 2) is indicated with an arrowhead. (E) Localization of the 21 YY2 binding sites identified in TS cells. Peaks are grouped
according to the location relative to transcribed annotated features in the database (NCBIM37).
TSS: within 2500 bp of a transcription start site;
O: overlapping feature;
DU: distal and upstream to TSS;
DD: distal from TSS and downstream of transcribed feature;
I: intergenic DNA at 100 kb from nearest annotated feature
(F) Association of peaks with lncRNA genes. The graph shows the YY2 binding sites that map within 5 kilobases with respect to
the nearest lncRNA gene (lncRNA within 5 kb), within 100 kilobases with respect to the nearest lncRNA gene (lncRNA within 100
kb) and other sites. (G) Expression levels of lncRNAs associated with YY2 binding sites (indicated in D) in Yy2-attenuated TS
cells as described in A-C.
doi:10.1371/journal.pone.0154268.g005
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6. The expression levels of several lncRNAs linked to YY2 binding sites are moderately
affected by Yy2-deficiency, suggesting regulation by YY2.
Discussion
Consistent with the presence of YY2 in both ES and TS cell lines, we show that YY2 is associ-
ated in vivo with selected transposable retroviral elements (RE) in both cell types. Independent
of the cell type assayed, we detected the highest levels of enrichment in ChIP assays for IAP
(Fig 2). Although binding of the zinc finger domain of YY2 (as a GST-fusion) to a target in
vitro was methylation-sensitive [1], IAP elements are reportedly methylated up to 90% in both
ES [39] and TS cells [40]. The YY2 binding to IAP elements we observe might therefore be
restricted to binding sites without GC dimers or to non-methylated copies of IAP. Despite the
robust binding of YY2 to IAP elements we detected in both ES and TS cells (Fig 2), no changes
in IAP levels were detected in cells with attenuated levels of Yy2 (Fig 5B). Therefore, YY2 bind-
ing to IAP elements may serve to either prime posterior regulation, or be functionally second-
ary to other regulation mechanisms.
Apart from IAP, we also found a weaker association of YY2 to MalR/Orr1 elements (Fig 2),
suggesting a potential role in their regulation. In addition to the role of YY1 in transcription of
HERVK [41], YY1 was recently shown to be involved in the regulation of MMLV silencing in
embryonic cells [42]. The new data we present here are consistent with the importance of
YY1-family proteins in the epigenetic control of retroviral elements scattered over the genome
in mammals, although no formal proof for YY2-dependent regulation of RE/ERV is available.
It is still unclear whether the binding of YY2 to RE and IAP elements is cooperative, comple-
mentary or competing with REX1 and YY1. The absence of a major de-regulation in MERVL
and IAP expression in Yy2-depleted TS cells could be due to overlapping functions of
YY1-family members in regulation of RE, although binding affinities may be different for dif-
ferent factors and in different cell types.
We report novel YY2 binding sites in chromatin in vivo, identified as those sites most
enriched in ChIP assays. We specifically assayed YY2 as opposed to YY1, as the YY2 serum
used does not cross-react with YY1 (S2 and S3 Figs). Enrichment was determined after deep
sequencing and compares reads identified in assays carried out using αYY2 serum with con-
trol assays using preimmune serum. The relatively low number of highly enriched sites (and
the low probability scores associated) precludes the rigorous identification of genome-wide
YY2 binding sites. Nevertheless, our approach method proved valid, as sites were easily con-
firmed in binding assays (Fig 3), and a consensus binding motif could be extracted (Fig 4A).
Moreover, attenuation of Yy2 levels in TS cells resulted in deregulated expression of at least a
subset of genes associated with selected putative YY2 binding sites (Fig 5G). In HeLa cells,
gene sets identified in expression microarrays that responded to YY1 and YY2 knock-down
turned out to be largely overlapping [8]. Subtle differences were described however, as YY1
controls more genes involved in proliferation, cytokinesis and DNA damage repair [7, 8],
while attenuation of YY2 levels reversed the YY1-depletion induced loss of proliferation and
improved cell survival after UV damage [8]. No members of these gene sets appear in our
analysis. We provide a list of novel putative YY2 binding sites, which may control genes not
regulated by YY1. Whether these loci influence differentiation or tissue-specific gene expres-
sion in TS cells or in placental derivatives remains to be addressed by detailed functional
analysis.
YY1 and its relative YY2 are mostly studied in the context of promoter regulation of target
genes [3, 7], although a good portion (26,1%) of YY1 binding sites defined in mouse myoblasts
In Vivo DNA Binding by Yin Yang 2
PLOSONE | DOI:10.1371/journal.pone.0154268 May 18, 2016 16 / 21
reside in intergenic regions [43]. A survey of the 21 most significant YY2 binding sites identified
in this manuscript (S2 Table; Fig 5E and 5F) suggested however that they were not confined to
or preferentially located in gene promoters. It remains a possibility that YY2 is involved in long-
range regulation as opposed to control of gene promoters. Alternatively, target genes in TS cells
may differ from those in more differentiated cells with acquired tissue specificity. Initial searches
for annotated features associated with putative YY2 binding sites in a range of 100 kb revealed
the presence of protein-coding genes in 12 out of 21 cases (S2 Table). Within the same 100 kb
range, ten out of 21 binding sites are associated with lncRNA genes (S2 Table and Fig 5F). Fur-
thermore, expression analysis in TS cells with attenuated levels of Yy2 revealed altered expres-
sion of selected lncRNA genes associated with binding peaks (Fig 5G). In light of our combined
mapping and expression data, we suggest that YY2might serve a more prominent role in regula-
tion of non-protein coding genes. This hypothesis is not unprecedented, as YY1 frequently
binds lncRNA genes in ES cells [38] and contributes to regulation of lncRNAs in skeletal myo-
genesis [35].
YY2 had been previously shown to bind in vitro to some but not all YY1 binding sites [3, 4].
Moreover, selection of duplex DNAs of randomized sequence for binding to zinc finger
domains, yielded oligonucleotides with the same CGCCATNTT consensus motif for both YY1
and YY2 binding [1]. Based on this result and in vitro binding assays it was concluded that the
overall DNA-binding patterns of YY1 and YY2 are similar. The putative YY2 binding sites
reported here share a consensus motif ANAGAAGTGG, similar to but not identical to consen-
sus motifs defined for YY1 in vivo. An AAGATGGCG motif was defined for cell-type-specific
binding of YY1 [44]. We defined a consensus AAAATGGCTG for in vivo REX1 binding
sites in mouse ES cells [33]. All such binding sites for YY1, YY2 and REX1 share the variant
A/GAA/GG/ATGG(C) core. We would suggest therefore, that the small difference in the zinc
finger region of each protein contributes to the preferred binding of either factor to a slightly
distinct binding site. Of course, binding specificity may be fine-tuned by additional factors.
The association with other DNA binding proteins co-determines binding affinity, allowing for
unique interactions guided by the distinct amino termini of each protein [45]. The epigenetic
status of the binding site may contribute, as already shown for methylation in case of YY1 [1].
Our data suggest that YY2 binding sites in vivo are distinct and separable from YY1 binding
sites. The novel in vivo YY2 binding sites identified may form the basis for future studies aimed
at defining unique functions of YY2.
Supporting Information
S1 Fig. Specificity of polyclonal serum towards YY2. (A) Western blots using αYY2 serum to
detect GST-YY2 fusion protein, after pre-incubation with YY2 or REX1 fusion proteins, in
the amounts indicated as molar excess. A band corresponding to GST-YY2 (GST-N-YY2) is
marked with an arrowhead. Migration of molecular weight standards is indicated to the right.
(B) Indirect immunofluorescence detection of YY2 (green) in confocal sections of 293T cells
(Top panels) or HA-YY2 transfected 293T cells (lower panels). Nuclei were counterstained
with DAPI as indicated, αYY2 staining was visualized using αRabbitBiotin followed by Strepta-
vidinAlexa488. (C) Western blots to detect YY2 in cell lysates of E14T ES cells transfected with
control shRNAs or shRNAs directed against Yy2 (shYy2). The arrowhead indicates the YY2
protein, which migrates as a 60 kD protein. Migration of molecular weight standards is indi-
cated to the left. Equivalent loading in each lane is demonstrated by stripping and reprobing
the membrane with αTUBULIN antibodies.
(TIF)
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S2 Fig. The αYY2 serum does not immunoprecipitate or detect YY1. Alignment between
YY2 and YY1 with the YY1 aminoacid sequence on top. Although YY2 shares good homology
with YY1 in the Zinc Finger region (not shown), only limited similarity (32,4% identity) was
found between the YY2 peptide used for antibody production (AA 1–173; the most C-terminal
residue 173 is indicated with a black arrowhead) and the non-ZincFinger region of YY1.
(TIF)
S3 Fig. Specificity of αYY2 serum. (A) and (B) The αYY2 serum specifically detects and
immunoprecipitates YY2 as opposed to YY1. Human kidney 293T cells were co-transfected
with plasmids expressing HA-tagged-intact YY1 or YY2 proteins. HA-YY1 or HA-YY2 were
detected using αYY2 blot (B, top panel) or αHA blot (A and B, bottom panel), respectively,
either directly in cell lysates (No IP) or after immunoprecipitation (IP) using αHAmonoclonal
antibody, αYY1 serum (Santa Cruz), αYY2 serum or PreI serum as indicated. Bands corre-
sponding to HA-YY1/YY2 are marked with open (YY1) and closed (YY2) arrowheads, respec-
tively. Bands corresponding to IgGs are indicated with arrows. Migration of molecular weight
standards is indicated to the right (both A panels) and to the left in panels B. Dilutions used
were as follows: αYY2 (1:14400) and αHA (1:100).
(TIF)
S4 Fig. YY2 expression in ES and TS cells. YY2 expression in ES and TS cells assessed by indi-
rect immunofluorescence. YY2 was detected with αYY2 and visualized using αRabbitBiotin
followed by StrepAlexa488, nuclei were stained with DAPI (in blue). (A) Representative wide-
field images of YY2 in ES and TS cells acquired in a fluorescence microscope (40X objective).
(B) Representative confocal sections (60X objective). In ES cell images 4, 5 and 6 and in TS cell
image 6, 2X zoom was applied. ES and TS cell images were taken from 3 and 2 independent
biological replicates, respectively.
(TIF)
S5 Fig. Expression ofMbtps2 and Yy2 transcripts. (A) Representation of theMbtps2-Yy2
locus and annotated transcripts, the arrow indicates the direction of transcription. The location
of primer pairs used to amplify annotated Yy2 transcripts (A-A, B-B and C-C) or annotated
Mbtps2 transcripts (D-D, E-E, F) is indicated. (B) Comparison of the amplification threshold
of different primer pairs depicted in A, the E-F pair is Ef-Fr. Amplification was measured by
quantitative RT-PCR as described in the M&M section. The amplification thresholds are repre-
sented as ΔCt values using Gapdh as a reference gene.
(TIF)
S1 Table. Primers used.
(XLS)
S2 Table. Putative in vivo YY2 binding sites. Additional data on the most significant peaks
identified (Table 2), and a site that obtained the maximum enrichment score when only reads
mapping to multiple locations in the genome were taken into account (S5T1). The table lists
each peak, and the distance to the TSS (in bp) of the nearest annotated feature (NCBI37/mm9)
in the database within a range of 100 kb. Locations are arbitrarily classified as Distal (D, 2.5–
100 kb away from TSS), Promoter (P, within 2.5 kb upstream of TSS), Overlapping transcribed
sequences (O) or NF (Not Found). For those peaks overlapping with transcribed sequences,
proximity to the relevant TSS is listed separately. The column “TSS (~2.5 Kb)” indicates which
peaks qualify as promoter proximal. The presence of nearby lncRNAs is indicated in the last
two columns. # This peak is localized 2352 bp downstream of the closest gene.
(PDF)
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